Global Prostate Cancer Diagnostics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Feb, 2020
|
Report ID: 116730
|
104
|
Pharmaceuticals and Healthcare
Summary
Market Overview
The global Prostate Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0% in the forecast period of 2020 to 2025 and will expected to reach USD 15640 million by 2025, from USD 11940 million in 2019.
The Prostate Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Prostate Cancer Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prostate Cancer Diagnostics
market has been segmented into Tumor Biomarker Tests, Imaging, Biopsy, Other, etc.
By Application, Prostate Cancer Diagnostics has been segmented into age < 55, age 55-75, age > 75, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Cancer Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostate Cancer Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Cancer Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Prostate Cancer Diagnostics market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Prostate Cancer Diagnostics markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Prostate Cancer Diagnostics Market Share Analysis
Prostate Cancer Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostate Cancer Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostate Cancer Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Prostate Cancer Diagnostics are: Genomic Health, MDx Health, Siemens Healthcare, Abbott, Roche, OPKO, Myriad Genetics, BioMeriux, DiaSorin, Beckman Coulter, Ambry Genetics, etc. Among other players domestic and global, Prostate Cancer Diagnostics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostate Cancer Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostate Cancer Diagnostics, with price, sales, revenue and global market share of Prostate Cancer Diagnostics in 2018 and 2019.
Chapter 3, the Prostate Cancer Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostate Cancer Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Prostate Cancer Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Prostate Cancer Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Market Overview
The global Prostate Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0% in the forecast period of 2020 to 2025 and will expected to reach USD 15640 million by 2025, from USD 11940 million in 2019.
The Prostate Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Prostate Cancer Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prostate Cancer Diagnostics
market has been segmented into Tumor Biomarker Tests, Imaging, Biopsy, Other, etc.
By Application, Prostate Cancer Diagnostics has been segmented into age < 55, age 55-75, age > 75, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Cancer Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostate Cancer Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Cancer Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Prostate Cancer Diagnostics market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Prostate Cancer Diagnostics markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Prostate Cancer Diagnostics Market Share Analysis
Prostate Cancer Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostate Cancer Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostate Cancer Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Prostate Cancer Diagnostics are: Genomic Health, MDx Health, Siemens Healthcare, Abbott, Roche, OPKO, Myriad Genetics, BioMeriux, DiaSorin, Beckman Coulter, Ambry Genetics, etc. Among other players domestic and global, Prostate Cancer Diagnostics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostate Cancer Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostate Cancer Diagnostics, with price, sales, revenue and global market share of Prostate Cancer Diagnostics in 2018 and 2019.
Chapter 3, the Prostate Cancer Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostate Cancer Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Prostate Cancer Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Prostate Cancer Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Prostate Cancer Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prostate Cancer Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Prostate Cancer Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 age < 55
1.3.3 age 55-75
1.3.4 age > 75
1.4 Overview of Global Prostate Cancer Diagnostics Market
1.4.1 Global Prostate Cancer Diagnostics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genomic Health
2.1.1 Genomic Health Details
2.1.2 Genomic Health Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Genomic Health SWOT Analysis
2.1.4 Genomic Health Product and Services
2.1.5 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 MDx Health
2.2.1 MDx Health Details
2.2.2 MDx Health Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 MDx Health SWOT Analysis
2.2.4 MDx Health Product and Services
2.2.5 MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Siemens Healthcare
2.3.1 Siemens Healthcare Details
2.3.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Siemens Healthcare SWOT Analysis
2.3.4 Siemens Healthcare Product and Services
2.3.5 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott SWOT Analysis
2.4.4 Abbott Product and Services
2.4.5 Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 OPKO
2.6.1 OPKO Details
2.6.2 OPKO Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 OPKO SWOT Analysis
2.6.4 OPKO Product and Services
2.6.5 OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Myriad Genetics
2.7.1 Myriad Genetics Details
2.7.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Myriad Genetics SWOT Analysis
2.7.4 Myriad Genetics Product and Services
2.7.5 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 BioMeriux
2.8.1 BioMeriux Details
2.8.2 BioMeriux Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BioMeriux SWOT Analysis
2.8.4 BioMeriux Product and Services
2.8.5 BioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 DiaSorin
2.9.1 DiaSorin Details
2.9.2 DiaSorin Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 DiaSorin SWOT Analysis
2.9.4 DiaSorin Product and Services
2.9.5 DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Beckman Coulter
2.10.1 Beckman Coulter Details
2.10.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Beckman Coulter SWOT Analysis
2.10.4 Beckman Coulter Product and Services
2.10.5 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ambry Genetics
2.11.1 Ambry Genetics Details
2.11.2 Ambry Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ambry Genetics SWOT Analysis
2.11.4 Ambry Genetics Product and Services
2.11.5 Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Prostate Cancer Diagnostics Manufacturer Market Share in 2019
3.3.2 Top 6 Prostate Cancer Diagnostics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Prostate Cancer Diagnostics Sales, Revenue and Market Share by Regions
4.1.1 Global Prostate Cancer Diagnostics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Regions (2015-2020)
4.2 North America Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
4.3 Europe Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
4.5 South America Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
5.1.1 North America Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
5.1.2 North America Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
5.2 United States Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
5.3 Canada Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
5.4 Mexico Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
6.1.1 Europe Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
6.2 Germany Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
6.3 UK Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
6.4 France Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
6.5 Russia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
6.6 Italy Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Prostate Cancer Diagnostics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Prostate Cancer Diagnostics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Prostate Cancer Diagnostics Revenue and Market Share by Regions (2015-2020)
7.2 China Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7.3 Japan Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7.4 Korea Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7.5 India Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7.7 Australia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
8.1.1 South America Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
8.1.2 South America Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
8.3 Argentina Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
9.3 Turkey Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
9.4 Egypt Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
9.5 South Africa Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Prostate Cancer Diagnostics Sales and Market Share by Type (2015-2020)
10.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Type (2015-2020)
10.3 Global Prostate Cancer Diagnostics Price by Type (2015-2020)
11 Global Prostate Cancer Diagnostics Market Segment by Application
11.1 Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
11.2 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2015-2020)
11.3 Global Prostate Cancer Diagnostics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2021-2025)
12.2 Prostate Cancer Diagnostics Market Forecast by Regions (2021-2025)
12.2.1 North America Prostate Cancer Diagnostics Market Forecast (2021-2025)
12.2.2 Europe Prostate Cancer Diagnostics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Prostate Cancer Diagnostics Market Forecast (2021-2025)
12.2.4 South America Prostate Cancer Diagnostics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Prostate Cancer Diagnostics Market Forecast (2021-2025)
12.3 Prostate Cancer Diagnostics Market Forecast by Type (2021-2025)
12.3.1 Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2025)
12.3.2 Global Prostate Cancer Diagnostics Market Share Forecast by Type (2021-2025)
12.4 Prostate Cancer Diagnostics Market Forecast by Application (2021-2025)
12.4.1 Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2025)
12.4.2 Global Prostate Cancer Diagnostics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
1 Market Overview
1.1 Prostate Cancer Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prostate Cancer Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Prostate Cancer Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 age < 55
1.3.3 age 55-75
1.3.4 age > 75
1.4 Overview of Global Prostate Cancer Diagnostics Market
1.4.1 Global Prostate Cancer Diagnostics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genomic Health
2.1.1 Genomic Health Details
2.1.2 Genomic Health Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Genomic Health SWOT Analysis
2.1.4 Genomic Health Product and Services
2.1.5 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 MDx Health
2.2.1 MDx Health Details
2.2.2 MDx Health Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 MDx Health SWOT Analysis
2.2.4 MDx Health Product and Services
2.2.5 MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Siemens Healthcare
2.3.1 Siemens Healthcare Details
2.3.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Siemens Healthcare SWOT Analysis
2.3.4 Siemens Healthcare Product and Services
2.3.5 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott SWOT Analysis
2.4.4 Abbott Product and Services
2.4.5 Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 OPKO
2.6.1 OPKO Details
2.6.2 OPKO Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 OPKO SWOT Analysis
2.6.4 OPKO Product and Services
2.6.5 OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Myriad Genetics
2.7.1 Myriad Genetics Details
2.7.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Myriad Genetics SWOT Analysis
2.7.4 Myriad Genetics Product and Services
2.7.5 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 BioMeriux
2.8.1 BioMeriux Details
2.8.2 BioMeriux Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BioMeriux SWOT Analysis
2.8.4 BioMeriux Product and Services
2.8.5 BioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 DiaSorin
2.9.1 DiaSorin Details
2.9.2 DiaSorin Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 DiaSorin SWOT Analysis
2.9.4 DiaSorin Product and Services
2.9.5 DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Beckman Coulter
2.10.1 Beckman Coulter Details
2.10.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Beckman Coulter SWOT Analysis
2.10.4 Beckman Coulter Product and Services
2.10.5 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ambry Genetics
2.11.1 Ambry Genetics Details
2.11.2 Ambry Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ambry Genetics SWOT Analysis
2.11.4 Ambry Genetics Product and Services
2.11.5 Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Prostate Cancer Diagnostics Manufacturer Market Share in 2019
3.3.2 Top 6 Prostate Cancer Diagnostics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Prostate Cancer Diagnostics Sales, Revenue and Market Share by Regions
4.1.1 Global Prostate Cancer Diagnostics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Regions (2015-2020)
4.2 North America Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
4.3 Europe Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
4.5 South America Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
5.1.1 North America Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
5.1.2 North America Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
5.2 United States Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
5.3 Canada Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
5.4 Mexico Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
6.1.1 Europe Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
6.2 Germany Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
6.3 UK Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
6.4 France Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
6.5 Russia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
6.6 Italy Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Prostate Cancer Diagnostics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Prostate Cancer Diagnostics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Prostate Cancer Diagnostics Revenue and Market Share by Regions (2015-2020)
7.2 China Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7.3 Japan Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7.4 Korea Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7.5 India Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
7.7 Australia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
8.1.1 South America Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
8.1.2 South America Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
8.3 Argentina Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
9.3 Turkey Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
9.4 Egypt Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
9.5 South Africa Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Prostate Cancer Diagnostics Sales and Market Share by Type (2015-2020)
10.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Type (2015-2020)
10.3 Global Prostate Cancer Diagnostics Price by Type (2015-2020)
11 Global Prostate Cancer Diagnostics Market Segment by Application
11.1 Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
11.2 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2015-2020)
11.3 Global Prostate Cancer Diagnostics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2021-2025)
12.2 Prostate Cancer Diagnostics Market Forecast by Regions (2021-2025)
12.2.1 North America Prostate Cancer Diagnostics Market Forecast (2021-2025)
12.2.2 Europe Prostate Cancer Diagnostics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Prostate Cancer Diagnostics Market Forecast (2021-2025)
12.2.4 South America Prostate Cancer Diagnostics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Prostate Cancer Diagnostics Market Forecast (2021-2025)
12.3 Prostate Cancer Diagnostics Market Forecast by Type (2021-2025)
12.3.1 Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2025)
12.3.2 Global Prostate Cancer Diagnostics Market Share Forecast by Type (2021-2025)
12.4 Prostate Cancer Diagnostics Market Forecast by Application (2021-2025)
12.4.1 Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2025)
12.4.2 Global Prostate Cancer Diagnostics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
List of Tables
Table 1. Global Prostate Cancer Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prostate Cancer Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Genomic Health Basic Information, Manufacturing Base and Competitors
Table 8. Genomic Health Prostate Cancer Diagnostics Major Business
Table 9. Genomic Health Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 10. Genomic Health SWOT Analysis
Table 11. Genomic Health Prostate Cancer Diagnostics Product and Services
Table 12. Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. MDx Health Basic Information, Manufacturing Base and Competitors
Table 14. MDx Health Prostate Cancer Diagnostics Major Business
Table 15. MDx Health Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 16. MDx Health SWOT Analysis
Table 17. MDx Health Prostate Cancer Diagnostics Product and Services
Table 18. MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table 20. Siemens Healthcare Prostate Cancer Diagnostics Major Business
Table 21. Siemens Healthcare Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 22. Siemens Healthcare SWOT Analysis
Table 23. Siemens Healthcare Prostate Cancer Diagnostics Product and Services
Table 24. Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Abbott Basic Information, Manufacturing Base and Competitors
Table 26. Abbott Prostate Cancer Diagnostics Major Business
Table 27. Abbott Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 28. Abbott SWOT Analysis
Table 29. Abbott Prostate Cancer Diagnostics Product and Services
Table 30. Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Roche Basic Information, Manufacturing Base and Competitors
Table 32. Roche Prostate Cancer Diagnostics Major Business
Table 33. Roche Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 34. Roche SWOT Analysis
Table 35. Roche Prostate Cancer Diagnostics Product and Services
Table 36. Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. OPKO Basic Information, Manufacturing Base and Competitors
Table 38. OPKO Prostate Cancer Diagnostics Major Business
Table 39. OPKO Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 40. OPKO SWOT Analysis
Table 41. OPKO Prostate Cancer Diagnostics Product and Services
Table 42. OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 44. Myriad Genetics Prostate Cancer Diagnostics Major Business
Table 45. Myriad Genetics Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 46. Myriad Genetics SWOT Analysis
Table 47. Myriad Genetics Prostate Cancer Diagnostics Product and Services
Table 48. Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. BioMeriux Basic Information, Manufacturing Base and Competitors
Table 50. BioMeriux Prostate Cancer Diagnostics Major Business
Table 51. BioMeriux Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 52. BioMeriux SWOT Analysis
Table 53. BioMeriux Prostate Cancer Diagnostics Product and Services
Table 54. BioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. DiaSorin Basic Information, Manufacturing Base and Competitors
Table 56. DiaSorin Prostate Cancer Diagnostics Major Business
Table 57. DiaSorin Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 58. DiaSorin SWOT Analysis
Table 59. DiaSorin Prostate Cancer Diagnostics Product and Services
Table 60. DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 62. Beckman Coulter Prostate Cancer Diagnostics Major Business
Table 63. Beckman Coulter Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 64. Beckman Coulter SWOT Analysis
Table 65. Beckman Coulter Prostate Cancer Diagnostics Product and Services
Table 66. Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Ambry Genetics Basic Information, Manufacturing Base and Competitors
Table 68. Ambry Genetics Prostate Cancer Diagnostics Major Business
Table 69. Ambry Genetics Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 70. Ambry Genetics SWOT Analysis
Table 71. Ambry Genetics Prostate Cancer Diagnostics Product and Services
Table 72. Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Prostate Cancer Diagnostics Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Prostate Cancer Diagnostics Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Prostate Cancer Diagnostics Sales by Regions (2015-2020) (K Units)
Table 76. Global Prostate Cancer Diagnostics Sales Market Share by Regions (2015-2020)
Table 77. Global Prostate Cancer Diagnostics Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Prostate Cancer Diagnostics Sales by Countries (2015-2020) (K Units)
Table 79. North America Prostate Cancer Diagnostics Sales Market Share by Countries (2015-2020)
Table 80. North America Prostate Cancer Diagnostics Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 82. Europe Prostate Cancer Diagnostics Sales by Countries (2015-2020) (K Units)
Table 83. Europe Prostate Cancer Diagnostics Sales Market Share by Countries (2015-2020)
Table 84. Europe Prostate Cancer Diagnostics Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Prostate Cancer Diagnostics Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Prostate Cancer Diagnostics Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Prostate Cancer Diagnostics Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Prostate Cancer Diagnostics Sales by Countries (2015-2020) (K Units)
Table 89. South America Prostate Cancer Diagnostics Sales Market Share by Countries (2015-2020)
Table 90. South America Prostate Cancer Diagnostics Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Prostate Cancer Diagnostics Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Prostate Cancer Diagnostics Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Prostate Cancer Diagnostics Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 96. Global Prostate Cancer Diagnostics Sales by Type (2015-2020) (K Units)
Table 97. Global Prostate Cancer Diagnostics Sales Share by Type (2015-2020)
Table 98. Global Prostate Cancer Diagnostics Revenue by Type (2015-2020) (USD Million)
Table 99. Global Prostate Cancer Diagnostics Revenue Share by Type (2015-2020)
Table 100. Global Prostate Cancer Diagnostics Sales by Application (2015-2020) (K Units)
Table 101. Global Prostate Cancer Diagnostics Sales Share by Application (2015-2020)
Table 102. Global Prostate Cancer Diagnostics Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Prostate Cancer Diagnostics Market Share Forecast by Regions (2021-2025)
Table 104. Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Prostate Cancer Diagnostics Market Share Forecast by Type (2021-2025)
Table 106. Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2025)
Table 107. Global Prostate Cancer Diagnostics Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Prostate Cancer Diagnostics Picture
Figure 2. Global Sales Market Share of Prostate Cancer Diagnostics by Type in 2019
Figure 3. Tumor Biomarker Tests Picture
Figure 4. Imaging Picture
Figure 5. Biopsy Picture
Figure 6. Other Picture
Figure 7. Prostate Cancer Diagnostics Sales Market Share by Application in 2018
Figure 8. age < 55 Picture
Figure 9. age 55-75 Picture
Figure 10. age > 75 Picture
Figure 11. Global Prostate Cancer Diagnostics Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2019
Figure 32. Global Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Prostate Cancer Diagnostics Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Prostate Cancer Diagnostics Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Prostate Cancer Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 39. Global Prostate Cancer Diagnostics Revenue Market Share by Regions in 2018
Figure 40. North America Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
Figure 41. Europe Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
Figure 43. South America Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
Figure 45. North America Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Prostate Cancer Diagnostics Sales Market Share by Countries (2015-2020)
Figure 47. North America Prostate Cancer Diagnostics Sales Market Share by Countries in 2018
Figure 48. North America Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Prostate Cancer Diagnostics Revenue Market Share by Countries in 2018
Figure 50. United States Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Prostate Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 56. Germany Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Prostate Cancer Diagnostics Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Prostate Cancer Diagnostics Revenue Market Share by Regions 2019
Figure 64. China Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Prostate Cancer Diagnostics Sales Market Share by Countries in 2019
Figure 71. South America Prostate Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 72. Brazil Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Prostate Cancer Diagnostics Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Prostate Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Prostate Cancer Diagnostics Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Prostate Cancer Diagnostics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Prostate Cancer Diagnostics Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Prostate Cancer Diagnostics Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Prostate Cancer Diagnostics Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Prostate Cancer Diagnostics Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Prostate Cancer Diagnostics Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
Table 1. Global Prostate Cancer Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prostate Cancer Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Genomic Health Basic Information, Manufacturing Base and Competitors
Table 8. Genomic Health Prostate Cancer Diagnostics Major Business
Table 9. Genomic Health Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 10. Genomic Health SWOT Analysis
Table 11. Genomic Health Prostate Cancer Diagnostics Product and Services
Table 12. Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. MDx Health Basic Information, Manufacturing Base and Competitors
Table 14. MDx Health Prostate Cancer Diagnostics Major Business
Table 15. MDx Health Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 16. MDx Health SWOT Analysis
Table 17. MDx Health Prostate Cancer Diagnostics Product and Services
Table 18. MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table 20. Siemens Healthcare Prostate Cancer Diagnostics Major Business
Table 21. Siemens Healthcare Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 22. Siemens Healthcare SWOT Analysis
Table 23. Siemens Healthcare Prostate Cancer Diagnostics Product and Services
Table 24. Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Abbott Basic Information, Manufacturing Base and Competitors
Table 26. Abbott Prostate Cancer Diagnostics Major Business
Table 27. Abbott Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 28. Abbott SWOT Analysis
Table 29. Abbott Prostate Cancer Diagnostics Product and Services
Table 30. Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Roche Basic Information, Manufacturing Base and Competitors
Table 32. Roche Prostate Cancer Diagnostics Major Business
Table 33. Roche Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 34. Roche SWOT Analysis
Table 35. Roche Prostate Cancer Diagnostics Product and Services
Table 36. Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. OPKO Basic Information, Manufacturing Base and Competitors
Table 38. OPKO Prostate Cancer Diagnostics Major Business
Table 39. OPKO Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 40. OPKO SWOT Analysis
Table 41. OPKO Prostate Cancer Diagnostics Product and Services
Table 42. OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 44. Myriad Genetics Prostate Cancer Diagnostics Major Business
Table 45. Myriad Genetics Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 46. Myriad Genetics SWOT Analysis
Table 47. Myriad Genetics Prostate Cancer Diagnostics Product and Services
Table 48. Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. BioMeriux Basic Information, Manufacturing Base and Competitors
Table 50. BioMeriux Prostate Cancer Diagnostics Major Business
Table 51. BioMeriux Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 52. BioMeriux SWOT Analysis
Table 53. BioMeriux Prostate Cancer Diagnostics Product and Services
Table 54. BioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. DiaSorin Basic Information, Manufacturing Base and Competitors
Table 56. DiaSorin Prostate Cancer Diagnostics Major Business
Table 57. DiaSorin Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 58. DiaSorin SWOT Analysis
Table 59. DiaSorin Prostate Cancer Diagnostics Product and Services
Table 60. DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 62. Beckman Coulter Prostate Cancer Diagnostics Major Business
Table 63. Beckman Coulter Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 64. Beckman Coulter SWOT Analysis
Table 65. Beckman Coulter Prostate Cancer Diagnostics Product and Services
Table 66. Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Ambry Genetics Basic Information, Manufacturing Base and Competitors
Table 68. Ambry Genetics Prostate Cancer Diagnostics Major Business
Table 69. Ambry Genetics Prostate Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 70. Ambry Genetics SWOT Analysis
Table 71. Ambry Genetics Prostate Cancer Diagnostics Product and Services
Table 72. Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Prostate Cancer Diagnostics Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Prostate Cancer Diagnostics Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Prostate Cancer Diagnostics Sales by Regions (2015-2020) (K Units)
Table 76. Global Prostate Cancer Diagnostics Sales Market Share by Regions (2015-2020)
Table 77. Global Prostate Cancer Diagnostics Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Prostate Cancer Diagnostics Sales by Countries (2015-2020) (K Units)
Table 79. North America Prostate Cancer Diagnostics Sales Market Share by Countries (2015-2020)
Table 80. North America Prostate Cancer Diagnostics Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 82. Europe Prostate Cancer Diagnostics Sales by Countries (2015-2020) (K Units)
Table 83. Europe Prostate Cancer Diagnostics Sales Market Share by Countries (2015-2020)
Table 84. Europe Prostate Cancer Diagnostics Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Prostate Cancer Diagnostics Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Prostate Cancer Diagnostics Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Prostate Cancer Diagnostics Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Prostate Cancer Diagnostics Sales by Countries (2015-2020) (K Units)
Table 89. South America Prostate Cancer Diagnostics Sales Market Share by Countries (2015-2020)
Table 90. South America Prostate Cancer Diagnostics Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Prostate Cancer Diagnostics Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Prostate Cancer Diagnostics Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Prostate Cancer Diagnostics Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 96. Global Prostate Cancer Diagnostics Sales by Type (2015-2020) (K Units)
Table 97. Global Prostate Cancer Diagnostics Sales Share by Type (2015-2020)
Table 98. Global Prostate Cancer Diagnostics Revenue by Type (2015-2020) (USD Million)
Table 99. Global Prostate Cancer Diagnostics Revenue Share by Type (2015-2020)
Table 100. Global Prostate Cancer Diagnostics Sales by Application (2015-2020) (K Units)
Table 101. Global Prostate Cancer Diagnostics Sales Share by Application (2015-2020)
Table 102. Global Prostate Cancer Diagnostics Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Prostate Cancer Diagnostics Market Share Forecast by Regions (2021-2025)
Table 104. Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Prostate Cancer Diagnostics Market Share Forecast by Type (2021-2025)
Table 106. Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2025)
Table 107. Global Prostate Cancer Diagnostics Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Prostate Cancer Diagnostics Picture
Figure 2. Global Sales Market Share of Prostate Cancer Diagnostics by Type in 2019
Figure 3. Tumor Biomarker Tests Picture
Figure 4. Imaging Picture
Figure 5. Biopsy Picture
Figure 6. Other Picture
Figure 7. Prostate Cancer Diagnostics Sales Market Share by Application in 2018
Figure 8. age < 55 Picture
Figure 9. age 55-75 Picture
Figure 10. age > 75 Picture
Figure 11. Global Prostate Cancer Diagnostics Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2019
Figure 32. Global Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Prostate Cancer Diagnostics Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Prostate Cancer Diagnostics Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Prostate Cancer Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 39. Global Prostate Cancer Diagnostics Revenue Market Share by Regions in 2018
Figure 40. North America Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
Figure 41. Europe Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
Figure 43. South America Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
Figure 45. North America Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Prostate Cancer Diagnostics Sales Market Share by Countries (2015-2020)
Figure 47. North America Prostate Cancer Diagnostics Sales Market Share by Countries in 2018
Figure 48. North America Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Prostate Cancer Diagnostics Revenue Market Share by Countries in 2018
Figure 50. United States Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Prostate Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 56. Germany Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Prostate Cancer Diagnostics Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Prostate Cancer Diagnostics Revenue Market Share by Regions 2019
Figure 64. China Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Prostate Cancer Diagnostics Sales Market Share by Countries in 2019
Figure 71. South America Prostate Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 72. Brazil Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Prostate Cancer Diagnostics Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Prostate Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Prostate Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Prostate Cancer Diagnostics Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Prostate Cancer Diagnostics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Prostate Cancer Diagnostics Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Prostate Cancer Diagnostics Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Prostate Cancer Diagnostics Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Prostate Cancer Diagnostics Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Prostate Cancer Diagnostics Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
